WO2011150939A1
(en)
|
2010-06-01 |
2011-12-08 |
Glycom A/S |
Polymorphs of 2'-o-fucosyllactose and producing thereof
|
US9102966B2
(en)
*
|
2010-07-16 |
2015-08-11 |
Glycom A/S |
Synthesis of sialooligosaccharide derivatives
|
MY192208A
(en)
|
2010-12-31 |
2022-08-08 |
Abbott Lab |
Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
|
WO2012092154A1
(en)
|
2010-12-31 |
2012-07-05 |
Abbott Laboratories |
Methods of using human milk oligosaccharides for improving airway respiratory health
|
WO2012092153A1
(en)
|
2010-12-31 |
2012-07-05 |
Abbott Laboratories |
Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
|
CA2822219C
(en)
|
2010-12-31 |
2020-12-29 |
Abbott Laboratories |
Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
|
CN103402376A
(zh)
|
2010-12-31 |
2013-11-20 |
雅培制药有限公司 |
促进有益细菌生长的中性人乳寡糖
|
CN103384525A
(zh)
|
2010-12-31 |
2013-11-06 |
雅培制药有限公司 |
用于调节炎症的人乳寡糖
|
NZ612504A
(en)
|
2010-12-31 |
2015-02-27 |
Abbott Lab |
Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
|
EP2678348A4
(en)
*
|
2011-02-21 |
2014-09-10 |
Glycom As |
NEW GLYCOSYL PHOSPHITE
|
US20140228554A1
(en)
|
2011-03-18 |
2014-08-14 |
Glycom A/S |
Synthesis of new fucose-containing carbohydrate derivatives
|
US20140323705A1
(en)
*
|
2011-05-13 |
2014-10-30 |
Markus Hederos |
Manufacture of lacto-n-tetraose
|
EP2522232A1
(en)
*
|
2011-05-13 |
2012-11-14 |
Nestec S.A. |
Nutritional products comprising human milk oligosaccharides and methods for manufacture thereof
|
CA2846603A1
(en)
|
2011-08-29 |
2013-03-07 |
Abbott Laboratories |
Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
|
WO2013044928A1
(en)
*
|
2011-09-30 |
2013-04-04 |
Glycom A/S |
Synthesis of hmo core structures
|
US20140271562A1
(en)
*
|
2011-10-18 |
2014-09-18 |
Nestec S.A. |
Composition for use in brain growth and/or cognitive and/or psychomotor development
|
WO2013091660A1
(en)
*
|
2011-12-23 |
2013-06-27 |
Glycom A/S |
A method for obtaining crystalline lacto-n-tetraose and lacto-n-neotetraose precursors and mixtures thereof
|
CN104428307A
(zh)
*
|
2012-06-14 |
2015-03-18 |
格礼卡姆股份公司 |
增强人乳寡糖或其前体或掺合物的稳定性和纯度以及增加其生物利用度
|
ITFI20120143A1
(it)
|
2012-07-12 |
2014-01-13 |
Inalco S A S Di Giovanni Cipollett I & C |
Polimorfi idrati e anidri del 2'-o-fucosillattosio e loro metodi di produzione.
|
DK2708145T3
(en)
|
2012-09-14 |
2016-07-18 |
Abbott Lab |
Nutritional Compositions for Use in Methods to Modulate Corticosterone Levels in Psychologically Stressed Individuals
|
ES2795665T3
(es)
|
2012-09-14 |
2020-11-24 |
Abbott Lab |
Procedimientos para aumentar la funcionalidad cerebral utilizando 2-fucosil-lactosa
|
WO2014075680A1
(en)
*
|
2012-11-13 |
2014-05-22 |
Glycom A/S |
Crystalline 3-o-fucosyllactose
|
US20160113952A1
(en)
|
2013-05-22 |
2016-04-28 |
Glycom As |
Synthetic Mixture of Oligosaccharides for Treating a Microbiota of a Mammal
|
CN103408609B
(zh)
*
|
2013-09-02 |
2016-01-13 |
济南尚博生物科技有限公司 |
一种制备1-S-2,3,4-三-O-苄基-l-硫代吡喃岩藻糖苷的方法
|
US9902984B2
(en)
|
2013-09-06 |
2018-02-27 |
Glycom A/S |
Fermentative production of oligosaccharides
|
EP2857410A1
(en)
*
|
2013-10-04 |
2015-04-08 |
Jennewein Biotechnologie GmbH |
Process for purification of 2´-fucosyllactose using simulated moving bed chromatography
|
EP2896628B1
(en)
|
2014-01-20 |
2018-09-19 |
Jennewein Biotechnologie GmbH |
Process for efficient purification of neutral human milk oligosaccharides (HMOs) from microbial fermentation
|
CN104098615A
(zh)
*
|
2014-06-09 |
2014-10-15 |
华中科技大学 |
一种以氢氧根离子型的碱为催化剂进行脱酰基化的方法
|
US11098075B2
(en)
*
|
2014-09-12 |
2021-08-24 |
Basf Se |
Method for preparing 2′-O-fucosyllactose
|
EP3209673B2
(en)
|
2014-10-24 |
2023-07-26 |
Glycom A/S |
Mixtures of human milk oligosaccharides
|
PL3212198T3
(pl)
|
2014-10-29 |
2021-08-23 |
Glycom A/S |
Syntetyczna kompozycja i sposób promowania gojenia się błony śluzowej
|
US11040049B2
(en)
|
2014-10-29 |
2021-06-22 |
Glycom A/S |
Composition comprising HMSs/HMOs and use thereof
|
US11040050B2
(en)
|
2014-10-29 |
2021-06-22 |
Glycom A/S |
Composition comprising HMSs/HMOs and use thereof
|
WO2016066175A1
(en)
|
2014-10-29 |
2016-05-06 |
Glycom A/S |
Synthetic composition and method for treating irritable bowel syndrome
|
WO2016086947A1
(en)
|
2014-12-05 |
2016-06-09 |
Glycom A/S |
Crystalline difucosyllactose
|
US10835544B2
(en)
|
2014-12-08 |
2020-11-17 |
Glycom A/S |
Synthetic composition for regulating satiety
|
US10987368B2
(en)
|
2014-12-08 |
2021-04-27 |
Glycom A/S |
Synthetic composition for preventing or treating CVD
|
US10828313B2
(en)
|
2014-12-08 |
2020-11-10 |
Glycom A/S |
Synthetic composition for treating metabolic disorders
|
US10881674B2
(en)
|
2014-12-08 |
2021-01-05 |
Glycom A/S |
Synthetic composition for treating metabolic disorders
|
ES2960750T3
(es)
|
2015-03-05 |
2024-03-06 |
Glycom As |
Oligosacáridos de la leche humana para el tratamiento de infecciones agudas del aparato respiratorio
|
WO2016157108A1
(en)
|
2015-03-31 |
2016-10-06 |
Glycom A/S |
Mixtures of human milk oligosaccharides comprising 3 '-o-sialyllactose
|
CN107614511B
(zh)
|
2015-06-09 |
2020-10-23 |
格礼卡姆股份公司 |
6’-SL、LNnT和LST c的三元混合物
|
RU2634707C2
(ru)
*
|
2015-07-23 |
2017-11-03 |
Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт особо чистых биопрепаратов" Федерального медико-биологического агентства |
Способ избирательного удаления О-ацетильных защитных групп в присутствии О-бензоильных
|
DK3349763T3
(en)
|
2015-09-14 |
2021-11-15 |
Glycom As |
Composition for use in microbiota modulation
|
EP3368046B1
(en)
|
2015-10-28 |
2022-07-27 |
Glycom A/S |
Synthetic composition and method for modulating brain function and behaviour
|
ES2950489T3
(es)
|
2015-10-28 |
2023-10-10 |
Glycom As |
Composición sintética y método para modular los trastornos de la emoción y del ánimo
|
CN108348536B
(zh)
|
2015-11-17 |
2021-09-24 |
格礼卡姆股份公司 |
治疗抗生素相关性并发症的合成组合物
|
US11957148B2
(en)
|
2015-12-15 |
2024-04-16 |
Societe Des Produits Nestle S.A. |
Mixture of human milk oligosaccharides(HMOs)
|
JP2019504091A
(ja)
*
|
2016-02-03 |
2019-02-14 |
ビーエーエスエフ ソシエタス・ヨーロピアBasf Se |
2’−o−フコシルラクトースの製造方法
|
EP3419630A4
(en)
|
2016-02-24 |
2019-11-06 |
Glycom A/S |
SYNTHETIC COMPOSITION OF MICROBIOTIC MODULATION
|
US20190100547A1
(en)
|
2016-03-09 |
2019-04-04 |
Basf Se |
Method for preparing 2'-o-fucosyllactose
|
KR101731263B1
(ko)
|
2016-04-25 |
2017-05-02 |
서울대학교 산학협력단 |
코리네박테리움 글루타미쿰을 이용한 2'-푸코실락토오스의 생산방법
|
ES2924137T3
(es)
|
2016-05-05 |
2022-10-04 |
Glycom As |
Composición que comprende HMOS para uso en el tratamiento de la hipersensibilidad y/o dolor visceral mediados por mastocitos
|
ES2938355T3
(es)
|
2016-05-05 |
2023-04-10 |
Glycom As |
Composición que comprende HMOS para el tratamiento de la diarrea no infecciosa
|
CN105924480B
(zh)
*
|
2016-05-10 |
2018-09-25 |
浙江大学 |
含岩藻糖三糖硫酸酯及其制备方法和应用
|
EP3458073B1
(en)
|
2016-05-19 |
2023-10-25 |
Glycom A/S |
Use of human milk oligosaccharides for treating migraine in patients with inflammatory bowel syndrome
|
EP3474861A4
(en)
|
2016-06-24 |
2020-04-15 |
Glycom A/S |
COMPOUNDS COMPRISING HMOS FOR THE PREVENTION AND / OR TREATMENT OF VIRAL AND / OR BACTERIAL INFECTIONS.
|
EP3589139A4
(en)
|
2017-03-01 |
2020-12-23 |
Glycom A/S |
SYNTHETIC COMPOSITION FOR MICROBIOTE MODULATION
|
EP3634429A4
(en)
|
2017-05-09 |
2020-11-04 |
Glycom A/S |
SYNTHETIC COMPOSITION FOR MICROBIOTE MODULATION
|
WO2018215960A1
(en)
|
2017-05-24 |
2018-11-29 |
Glycom A/S |
Synthetic composition comprising one or more human milk oligosaccharides (hmos)
|
US11541068B2
(en)
|
2017-05-24 |
2023-01-03 |
Glycom A/S |
HMO compositions and methods for reducing autism spectrum disorder symptoms
|
EP3672600A4
(en)
|
2017-08-21 |
2021-05-19 |
Glycom A/S |
SYNTHETIC COMPOSITION TO REDUCE ALLERGY SYMPTOMS
|
EP3450443A1
(en)
|
2017-08-29 |
2019-03-06 |
Jennewein Biotechnologie GmbH |
Process for purifying sialylated oligosaccharides
|
WO2019087140A1
(en)
|
2017-11-02 |
2019-05-09 |
Glycom A/S |
One or more hmos for reducing or preventing fatigue and/or improving focus or concentration
|
JP7327724B2
(ja)
|
2017-11-30 |
2023-08-16 |
グリコム・アクティーゼルスカブ |
小麦過敏症を処置するためのhmoの混合物
|
US11602545B2
(en)
|
2017-12-05 |
2023-03-14 |
Glycom A/S |
Human milk oligosaccharides for treating migraine
|
EP3743078A4
(en)
|
2017-12-22 |
2022-01-19 |
Glycom A/S |
COMPOSITION WITH HMOs TO PREVENT OR REDUCE NOCICEPTION
|
CN108084234A
(zh)
*
|
2018-01-23 |
2018-05-29 |
佛山科学技术学院 |
双重随机糖基化合成三糖的方法
|
CN112165947A
(zh)
|
2018-05-31 |
2021-01-01 |
格礼卡姆股份公司 |
用于治疗自身免疫性疾病的hmo混合物
|
WO2020079114A1
(en)
|
2018-10-18 |
2020-04-23 |
Basf Se |
Method for obtaining crystalline 2'-fucosyllactose
|
KR20210104773A
(ko)
|
2018-12-19 |
2021-08-25 |
글리콤 에이/에스 |
저-포드맵 식단을 사용한 인간 치료를 위한 조성물 및 방법
|
EP3741770A1
(en)
|
2019-05-21 |
2020-11-25 |
Jennewein Biotechnologie GmbH |
Purification of oligosaccharides from a fermentation broth by using filtration
|
CN111588726A
(zh)
*
|
2020-04-28 |
2020-08-28 |
南开大学 |
2′-岩藻糖基乳糖调节宿主肠道菌群及增强肠屏障的应用
|
WO2022223430A1
(en)
|
2021-04-19 |
2022-10-27 |
Dsm Ip Assets B.V. |
A composition of enzymes and human milk oligosaccharides
|
WO2023099297A1
(en)
*
|
2021-12-02 |
2023-06-08 |
Dsm Ip Assets B.V. |
Synthesis of hmo butyrate
|
WO2024013393A1
(en)
|
2022-07-15 |
2024-01-18 |
Dsm Ip Assets B.V. |
Combination of bifidobacterium and fucosylated hmo for use in increasing nmn or nad+
|